DHA 20mg / PPQ 160mg, blister of 3 tab., 5-12 kg

STD DORADHAP1T1

Valid Article

Former Code(s): DORADHAP01-
Article is intended to be used with children (<12 years) ONLY.
6.5.3.1 - For curative treatment
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
P01BF05
Anatomical Therapeutic Chemical Classification according to WHOCC
The order of this product needs to be justified and is only acceptable under certain conditions.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   

Add Kit To Wishlist

   

DIHYDROARTEMISININ (DHA)/PIPERAQUINE (PPQ)

Therapeutic Action

Fixed-dose combination (FDC) of two antimalarials

Indications

First or second-line treatment of uncomplicated malaria, depending on the context

Some restricted information has been hidden. Sign in to see this information

Instructions for use

Blister presentation for 3 days treatment.

5 different presentations for 5 categories of weight:

  • infants / small children 5-12 kg: blister of 3 tab. (20/160 mg)
  • children 13-23 kg: blister of 3 tab. (40/320 mg)
  • adolescents 24-34 kg: blister of 6 tab. (40/320 mg)
  • adults 35-74 kg: blister of 9 tab. (40/320 mg)
  • tall adults 75-100 kg: blister of 12 tab. (40/320 mg)

Presentations must be ordered for all 5 weight categories.

The quantity to be ordered is calculated per blister (= one treatment), not per tablet.

Storage

  • Below 25°C ‐ Protect from sunlight ‐ Protect from humidity
  • Shelf life: maximum 24 months